Viatris (VTRS) EBIT (2019 - 2026)
Viatris (VTRS) recorded quarterly EBIT of -$79.7 million in Q1 2026, up 58.64% quarter-over-quarter from -$192.7 million in Q4 2025, and up 97.23% on a YoY basis from -$40.4 million in Q1 2025.
Viatris (VTRS) EBIT (2019 - 2026) Analysis & Trends
Viatris' EBIT history runs 8 years deep, the most recent figure standing at -$79.7 million for Q1 2026.
- In Q1 2026, EBIT rose 97.23% year-over-year to -$79.7 million; the TTM figure through Mar 2026 stood at $139.4 million (up 104.53% YoY), while the FY2025 annual figure was -$2.7 billion, down 26467.33% from the prior year.
- EBIT was -$79.7 million for Q1 2026 at Viatris, up from -$192.7 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $707.4 million in Q1 2022 to a low of -$2.9 billion in Q1 2025.
- Historically, EBIT has averaged -$20.7 million across 5 years, with a median of $203.9 million in 2024.
- The sharpest annual moves came in 2022 and 2025: EBIT surged 1247.91% in 2022, then plunged 1513.54% in 2025.
- A 5-year view of EBIT shows it stood at -$201.3 million in 2022, then sank by 125.78% to -$454.5 million in 2023, then surged by 60.44% to -$179.8 million in 2024, then dropped by 7.17% to -$192.7 million in 2025, then surged by 58.64% to -$79.7 million in 2026.
- The last three EBIT figures came in at -$79.7 million (Q1 2026), -$192.7 million (Q4 2025), and $178.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -78.32 Mn |
| 10 | Viatris | - | - | 1.16 Bn | -79.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.70 Mn |
| Dec 31, 2025 | -192.70 Mn |
| Sep 30, 2025 | 178.80 Mn |
| Jun 30, 2025 | 233.00 Mn |
| Mar 31, 2025 | -2.88 Bn |
| Dec 31, 2024 | -179.80 Mn |
| Sep 30, 2024 | 225.90 Mn |
| Jun 30, 2024 | -239.90 Mn |
| Mar 31, 2024 | 203.90 Mn |
| Dec 31, 2023 | -454.50 Mn |
| Sep 30, 2023 | 451.70 Mn |
| Jun 30, 2023 | 369.20 Mn |
| Mar 31, 2023 | 399.80 Mn |
| Dec 31, 2022 | -201.30 Mn |
| Sep 30, 2022 | 560.10 Mn |
| Jun 30, 2022 | 548.70 Mn |
| Mar 31, 2022 | 707.40 Mn |
| Dec 31, 2021 | -77.60 Mn |
| Sep 30, 2021 | 357.60 Mn |
| Jun 30, 2021 | -47.80 Mn |